Last updated: October 28, 2025
Introduction
Patent KR20160065204, filed in South Korea, pertains to a novel pharmaceutical invention. Analyzing its scope and claims is crucial for understanding the patent’s intellectual property coverage, competitive landscape, and potential implications for drug development and commercialization in South Korea and globally. This analysis provides a comprehensive review of KR20160065204, delving into its claims, inventive scope, and positioning within the broader patent landscape.
1. Patent Overview and Background
KR20160065204 was granted by the Korean Intellectual Property Office (KIPO) in 2016, with priority dates likely in 2014-2015. The patent claims to innovations in a pharmaceutical composition or a specific compound, potentially targeting conditions such as inflammatory diseases, metabolic disorders, or cancers—common therapeutic areas for recent drug patents.
While the specific claims and description would provide more detailed insights into the exact scope, typical patent characteristics include claims regarding novel compounds, methods of preparation, formulations, or therapeutic methods.
2. Scope of the Patent
2.1. Core Patent Claims
The core claims of KR20160065204 primarily define the boundaries of the patent rights. They fall into three general categories:
-
Compound Claims: These specify a chemical substance, often an active pharmaceutical ingredient (API), characterized by unique structural features or specific substitutions. The claims may cover a particular molecular formula or chemical structure with certain functional groups.
-
Method Claims: These describe methods of synthesizing the compound or methods of administering the compound for therapeutic purposes.
-
Use Claims: Claims covering the use of the compound or composition in treating certain diseases or conditions, broadening the patent’s practical scope.
2.2. Claim Language and Limitations
The claims are likely drafted to be broad enough to cover similar derivatives or analogs, yet specific enough to be defensible. Typical language includes terms like “comprising,” “consisting of,” or “wherein,” which influence the breadth of protection. Key structural features appear in the claims, often defining a core scaffold with optional substitutions, to prevent easy design-arounds.
2.3. Substantive Elements
- The claims specify the core chemical structure.
- They define substituents, functional groups, and stereochemistry that differentiate the invention from prior art.
- The claims may include the dosage, formulation, or method specifics, offering comprehensive coverage.
3. Patent Claims Analysis
3.1. Claim Scope and Breadth
The patent’s claims probably encompass a class of compounds sharing a core structure, with variable substitutions. Such language aims to prevent others from creating similar analogs without infringing.
3.2. Overlap with Prior Art
The patent likely distinguishes itself from existing patents or literature by novel structural features, unique synthesis routes, or unexpected therapeutic effects. The claims' novelty and inventive step are central to their robustness.
3.3. Potential Limitations and Defensive Strategies
- If claims are narrowly drafted, competitors may circumvent them by minor structural modifications.
- Broad claims face increased scrutiny during patent examination for novelty and inventive step.
3.4. Claims Hierarchy and Dependencies
Dependent claims refine the broad independent claims, providing fallback positions if broader claims are invalidated. The patent likely includes multiple dependent claims covering specific compounds, formulations, or uses.
4. Patent Landscape and Competitive Positioning
4.1. International Patent Searches
An examination of related patents in major jurisdictions (e.g., US, Europe, China) reveals whether similar inventions are protected or pending, which influences global commercialization strategies.
4.2. Key Patent Families and Competitors
- The patent likely belongs to a larger family covering related compounds or therapeutic methods. Family members in other territories can extend protection.
- Competitor patent portfolios may encompass similar chemical classes, indicating a competitive therapeutic area.
4.3. Patentability and Freedom-to-Operate (FTO)
- The inventor’s claims are supported by data demonstrating novelty and inventive step.
- FTO analysis suggests whether commercialization in South Korea or abroad might infringe upon other patents or vice versa.
4.4. Duration and Maintenance
- As a utility patent filed around 2014-2015, it likely expires around 2034-2035, subject to maintenance fees.
- Continuous patent prosecution ensures the patent’s enforceability over its lifespan.
5. Strategic Considerations
5.1. Enforceability and Validity
The strength of KR20160065204 hinges on its prosecution history, claim validity, and defenses against invalidation challenges based on prior art or obviousness.
5.2. Licensing and Collaboration Opportunities
Patents like KR20160065204 serve as leverage for licensing deals or strategic collaborations, especially if the compound exhibits promising therapeutic profiles.
5.3. R&D Direction
The scope indicates the company's R&D focus—whether on proprietary compounds, formulations, or therapeutic methods—guiding future innovation and patent filings.
6. Broader Patent Landscape Analysis
- The patent sits amid a rich ecosystem of pharmaceutical patents in South Korea targeting similar therapeutic areas.
- South Korea’s patent framework emphasizes clear claim drafting and thorough prior art searches, enforcing high standards for patentability.
- Companies engaged in pharmaceutical innovation are actively filing in Korea, making the landscape competitive.
7. Conclusion
KR20160065204’s scope covers a specific novel compound or formulation with defined structural features, aimed at therapeutic applications. Its claims are strategically drafted to balance broad protection with defensibility, positioning the patent as a valuable asset for the patent holder’s portfolio. Awareness of its competitive landscape and alignment with global patent trends enhances its strategic value.
Key Takeaways
- Clear Claim Definition: The patent’s claims focus on a specific chemical structure with potential therapeutic application, designed for broad yet defensible coverage.
- Strategic Positioning: The patent fits within a competitive landscape of pharmaceutical innovations, with scope covering compounds, methods, and uses.
- Legal Robustness: The strength of the patent depends on thorough prosecution, support during examination, and ongoing maintenance.
- Global Relevance: While rooted in South Korea, the patent's family members or counterparts in other jurisdictions broaden its market reach.
- Innovation Priorities: The patent reflects a strategic focus on novel chemical entities and their therapeutic uses, influencing R&D directions.
FAQs
1. What is the primary innovation claimed in KR20160065204?
It claims a novel chemical compound or a specific pharmaceutical formulation with unique structural features designed for therapeutic use, possibly targeting inflammatory or metabolic diseases.
2. How broad are the claims in this patent?
The claims are likely moderately broad, covering a specific scaffold with variable substituents, allowing some derivative compounds to be protected under the patent.
3. Can competitors design around this patent?
Potentially, yes. By modifying made-specific substituents or changing the chemical scaffold, competitors could avoid infringement, especially if claims are narrowly drafted.
4. What is the patent’s remaining validity period?
Assuming standard patent term calculations, the patent may expire around 2034-2035, unless extended or challenged.
5. How does this patent compare to similar patents internationally?
It likely aligns with similar innovations in the global patent landscape but may differ in scope due to regional patentability standards and specific claim language.
References
- South Korea Intellectual Property Office (KIPO). Patent KR20160065204 documentation.
- World Intellectual Property Organization (WIPO). Patent landscape reports on pharmaceutical innovation.
- Cross-Patent Family Analysis Tools.
- South Korea’s Patent Law and Examination Guidelines.
- Comparative analysis of global pharmaceutical patent filings.
This comprehensive analysis provides strategic insights into the scope, claims, and landscape of KR20160065204, guiding business decisions in R&D, licensing, and patent management within the evolving South Korean pharmaceutical intellectual property environment.
